Literature DB >> 9517959

Role of superoxide in catalase-peroxidase-mediated isoniazid action against mycobacteria.

J Y Wang1, R M Burger, K Drlica.   

Abstract

Isoniazid (INH) activation in vitro is associated with reduction of the mycobacterial ferric KatG catalase-peroxidase by hydrazine and reaction with O2 to form an oxyferrous enzyme complex. Since this complex could also form directly via reaction of ferric KatG with superoxide, intracellular activation might be responsive to superoxide concentration. When Mycobacterium smegmatis carrying the M. bovis katG gene was treated with nontoxic levels of plumbagin, a generator of superoxide, the bacteriostatic activity of INH increased unless a plasmid-borne superoxide dismutase gene was also present. Thus, endogenous superoxide probably contributes to intracellular activation of INH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517959      PMCID: PMC105525     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium.

Authors:  V Escuyer; N Haddad; C Frehel; P Berche
Journal:  Microb Pathog       Date:  1996-01       Impact factor: 3.738

2.  Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.

Authors:  S Dhandayuthapani; Y Zhang; M H Mudd; V Deretic
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

3.  Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

4.  Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis.

Authors:  B Heym; P M Alzari; N Honoré; S T Cole
Journal:  Mol Microbiol       Date:  1995-01       Impact factor: 3.501

5.  Manganese-mediated oxidative damage of cellular and isolated DNA by isoniazid and related hydrazines: non-Fenton-type hydroxyl radical formation.

Authors:  K Ito; K Yamamoto; S Kawanishi
Journal:  Biochemistry       Date:  1992-11-24       Impact factor: 3.162

6.  Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.

Authors:  A Quémard; C Lacave; G Lanéelle
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.

Authors:  A Banerjee; E Dubnau; A Quemard; V Balasubramanian; K S Um; T Wilson; D Collins; G de Lisle; W R Jacobs
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

8.  Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.

Authors:  B Heym; S T Cole
Journal:  Res Microbiol       Date:  1992-09       Impact factor: 3.992

9.  Effects of peroxides on susceptibilities of Escherichia coli and Mycobacterium smegmatis to isoniazid.

Authors:  J L Rosner; G Storz
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.

Authors:  A Dessen; A Quémard; J S Blanchard; W R Jacobs; J C Sacchettini
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

View more
  11 in total

Review 1.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

2.  A ferritin mutant of Mycobacterium tuberculosis is highly susceptible to killing by antibiotics and is unable to establish a chronic infection in mice.

Authors:  Ruchi Pandey; G Marcela Rodriguez
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

3.  Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis.

Authors:  Hayden T Pacl; Vineel P Reddy; Vikram Saini; Krishna C Chinta; Adrie J C Steyn
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

4.  Isonicotinic acid hydrazide conversion to Isonicotinyl-NAD by catalase-peroxidases.

Authors:  Ben Wiseman; Xavi Carpena; Miguel Feliz; Lynda J Donald; Miquel Pons; Ignacio Fita; Peter C Loewen
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

5.  Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis.

Authors:  Kelly Flentie; Gregory A Harrison; Hasan Tükenmez; Jonathan Livny; James A D Good; Souvik Sarkar; Dennis X Zhu; Rachel L Kinsella; Leslie A Weiss; Samantha D Solomon; Miranda E Schene; Mette R Hansen; Andrew G Cairns; Martina Kulén; Torbjörn Wixe; Anders E G Lindgren; Erik Chorell; Christoffer Bengtsson; K Syam Krishnan; Scott J Hultgren; Christer Larsson; Fredrik Almqvist; Christina L Stallings
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-06       Impact factor: 11.205

6.  Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid.

Authors:  Vanja M Bulatovic; Nancy L Wengenack; James R Uhl; Leslie Hall; Glenn D Roberts; Franklin R Cockerill; Frank Rusnak
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 7.  Molecular biology of drug resistance in Mycobacterium tuberculosis.

Authors:  Tasha Smith; Kerstin A Wolff; Liem Nguyen
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis.

Authors:  Michel Nguyen; Annaïk Quémard; Sylvain Broussy; Jean Bernadou; Bernard Meunier
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

9.  Identification of potential inhibitor targeting enoyl-acyl carrier protein reductase (InhA) in Mycobacterium tuberculosis: a computational approach.

Authors:  V Shanthi; K Ramanathan
Journal:  3 Biotech       Date:  2013-06-18       Impact factor: 2.406

10.  Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs.

Authors:  Kriti Sikri; Priyanka Duggal; Chanchal Kumar; Sakshi Dhingra Batra; Atul Vashist; Ashima Bhaskar; Kritika Tripathi; Tavpritesh Sethi; Amit Singh; Jaya Sivaswami Tyagi
Journal:  Redox Biol       Date:  2018-01-03       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.